Topic

Aetna (CVS Health)

A collection of 1351 issues

Myths vs. Facts: Getting Natpara (Parathyroid Hormone) Covered by Aetna CVS Health in Michigan

Important Update: Takeda will permanently discontinue all Natpara shipments on December 31, 2025. New patient starts are typically denied due to no commercial supply. If you're currently on Natpara through the Special Use Program, work with your endocrinologist immediately to plan your transition to alternatives like Yorvipath or

Myths vs. Facts: Getting Gamifant (Emapalumab) Covered by Aetna CVS Health in North Carolina

Answer Box: Getting Gamifant (Emapalumab) Covered by Aetna CVS Health in North Carolina Fastest path to approval: Submit prior authorization through CVS Caremark portal with documented primary HLH diagnosis (HLH-2004 criteria), proof of conventional therapy failure (etoposide + dexamethasone), and hematologist medical necessity letter. If denied, use North Carolina's

Renewing Tepezza (Teprotumumab) Approval with Aetna CVS Health in New York: Complete Guide to Documentation and Timelines

Answer Box: Renewing Tepezza Coverage Most Aetna CVS Health plans limit Tepezza to one 8-infusion course per lifetime. Renewal beyond 8 doses requires exceptional documentation showing unmet clinical need plus peer-reviewed evidence supporting extended treatment. Start renewal requests 2-4 weeks before your final scheduled infusion. If denied, New York residents

How to Get Gilenya (Fingolimod) Covered by Aetna (CVS Health) in Texas: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Gilenya (Fingolimod) Covered by Aetna (CVS Health) in Texas Aetna requires prior authorization for Gilenya (fingolimod) with documentation of relapsing MS diagnosis, baseline safety tests (EKG, eye exam), and often proof of trying preferred first-line therapies. Your neurologist submits the PA via Aetna's provider portal

Myths vs. Facts: Getting Garadacimab Covered by Aetna (CVS Health) in Washington - Complete Prior Authorization Guide

Answer Box: Getting Garadacimab Covered by Aetna in Washington Garadacimab requires prior authorization from Aetna (CVS Health) with confirmed HAE diagnosis, specialist prescription, and often documented failures of step-therapy alternatives. Washington residents have strong appeal rights through the Office of Insurance Commissioner, including expedited reviews (72 hours) and binding external

How to Get Kalydeco (ivacaftor) Covered by Aetna (CVS Health) in Ohio: Complete Prior Authorization and Appeals Guide

Quick Answer: To get Kalydeco (ivacaftor) covered by Aetna (CVS Health) in Ohio, you need prior authorization with CFTR genetic testing proving an FDA-responsive mutation, CF specialist prescription, and clinical documentation. If denied, use Ohio's external review process within 180 days. Start by gathering your genetic test results

How to Get Mepsevii (vestronidase alfa-vjbk) Covered by Aetna (CVS Health) in California: Prior Authorization Guide and Appeal Process

Answer Box: Getting Mepsevii Covered by Aetna (CVS Health) in California Mepsevii (vestronidase alfa-vjbk) requires prior authorization from Aetna with strict medical necessity criteria. Success requires: (1) confirmed MPS VII diagnosis via enzyme assay or genetic testing, (2) elevated urinary GAGs ≥2× normal, and (3) prescription by a metabolic specialist.

Work With Your Doctor to Get Amvuttra (vutrisiran) Approved by Aetna CVS Health in Texas: Complete Provider Collaboration Guide

Answer Box: Getting Amvuttra (vutrisiran) Approved by Aetna CVS Health in Texas Amvuttra (vutrisiran) requires prior authorization from Aetna CVS Health for both hATTR polyneuropathy and ATTR cardiomyopathy. Success depends on partnering with your neurologist or cardiologist to submit comprehensive documentation including genetic testing, tissue diagnosis, and symptom scores. If

How Long Does It Take to Get Fintepla (Fenfluramine) Approved by Aetna (CVS Health) in New Jersey? Complete Timeline & Appeals Guide

Answer Box: Getting Fintepla Approved by Aetna (CVS Health) in New Jersey Standard timeline: 15-30 days for prior authorization; 72 hours for urgent cases. Aetna requires documented failure of ≥2 preferred antiseizure medications, REMS enrollment (prescriber and patient), and baseline echocardiogram for Dravet syndrome or Lennox-Gastaut syndrome patients ≥2 years

How to Get Koselugo (selumetinib) Covered by Aetna (CVS Health) in Florida: Complete Prior Authorization Guide

Answer Box: Getting Koselugo (selumetinib) Covered by Aetna (CVS Health) in Florida Koselugo (selumetinib) is typically covered by Aetna (CVS Health) as a specialty medication with prior authorization for pediatric patients ≥2 years with NF1 and symptomatic, inoperable plexiform neurofibromas. The fastest path to approval: 1) Have your pediatric oncologist